Results 111 to 120 of about 15,211 (199)

Characteristics and outcomes of patients with pediatric-onset non-mastocytosis mast cell activation disorders: A CEREMAST study. [PDF]

open access: yesPediatr Allergy Immunol
Weiss M   +25 more
europepmc   +1 more source

INVA8001, a novel and highly selective chymase inhibitor, ameliorates liver inflammation, fibrosis, and hyperplasia in Mdr2 knockout mice. [PDF]

open access: yesFront Med (Lausanne)
Sharma S   +8 more
europepmc   +1 more source

Granzyme B from mast cells contributes to choroidal neovascularization in a model of wet age-related macular degeneration. [PDF]

open access: yesFront Immunol
Uppal M   +13 more
europepmc   +1 more source

World Allergy Organization survey on the diagnosis and management trends of perioperative anaphylaxis. [PDF]

open access: yesWorld Allergy Organ J
Gonzalez-Estrada A   +19 more
europepmc   +1 more source

Reconsidering cytoreductive therapy in high-risk pediatric mastocytosis: From diffuse cutaneous to smoldering systemic disease. [PDF]

open access: yesJ Allergy Clin Immunol Glob
Giavina-Bianchi M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy